Newsfeeds - Spark Newswire

2 minute read

Earnings

Vivint Smart Home’s Return On Capital Employed Insights

May 16, 9:59 AM

According to Benzinga Pro data, during Q1, Vivint Smart Home (NYSE:VVNT) posted sales of $392.75 million. Earnings were up 48.69%, but Vivint Smart Home still reported an overall loss of $27.43 million.

VVNT

6 minute read

81 Biggest Movers From Yesterday

By Lisa Levin

May 5, 4:31 AM

Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday.

ACON

19 minute read

Earnings Scheduled For May 3, 2022

By Benzinga Insights

May 3, 4:52 AM

Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.

ABNB

48 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

April 28, 3:31 PM

During Thursday, 849 stocks hit new 52-week lows.

AADI

15 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

April 19, 11:38 AM

On Tuesday, 242 companies hit new 52-week lows.

ACRX

5 minute read

58 Biggest Movers From Yesterday

By Lisa Levin

January 7, 5:29 AM

Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe is no long active.

AACG

2 minute read

12 Consumer Discretionary Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

January 6, 1:36 PM

AACG

32 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

January 6, 1:14 PM

On Thursday, 615 stocks hit new 52-week lows.

AAOI

2 minute read

Movers

11 Consumer Discretionary Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

December 14, 2:06 PM

Gainers

AOUT

3 minute read

34 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

December 14, 1:31 PM

Gainers Exicure, Inc. (NASDAQ: XCUR) rose 41.8% to $0.3830. Exicure’s Audit Committee recently concluded that Grant Corbett misreported raw data from certain R&D experiments related to XCUR-FXN preclinical program.

ADGI